Clinical Trial Update: Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating regimens containing raltegravir to prevent mother-to-child transmission of HIV was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Fundação Bahiana de Infectologia | Conditions: HIV, Pregnancy | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-10-15